A detailed history of Nitorum Capital, L.P. transactions in Mannkind Corp stock. As of the latest transaction made, Nitorum Capital, L.P. holds 9,157,507 shares of MNKD stock, worth $63 Million. This represents 6.38% of its overall portfolio holdings.

Number of Shares
9,157,507
Previous 10,079,558 9.15%
Holding current value
$63 Million
Previous $52.6 Million 9.3%
% of portfolio
6.38%
Previous 5.97%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.01 - $6.7 $4.62 Million - $6.18 Million
-922,051 Reduced 9.15%
9,157,507 $57.5 Million
Q1 2024

May 15, 2024

SELL
$3.25 - $5.27 $2.44 Million - $3.96 Million
-751,832 Reduced 6.94%
10,079,558 $45.7 Million
Q4 2023

Feb 14, 2024

BUY
$3.34 - $4.29 $1.2 Million - $1.55 Million
360,621 Added 3.44%
10,831,390 $39.4 Million
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.45 $22 Million - $30.7 Million
5,632,585 Added 116.42%
10,470,769 $43.2 Million
Q2 2023

Aug 14, 2023

BUY
$3.72 - $4.79 $18 Million - $23.2 Million
4,838,184 New
4,838,184 $19.7 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.77B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Nitorum Capital, L.P. Portfolio

Follow Nitorum Capital, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nitorum Capital, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Nitorum Capital, L.P. with notifications on news.